QuitAdvisorMD: A Point-of-care Tool for Brief Smoking Cessation Interventions

Official Title: “QuitAdvisorMD: A Point-of-care Tool for Brief Smoking Cessation Interventions”

QuitAdvisorMD: A point-of-care tool for brief smoking cessation interventions Under a Phase II SBIR grant supported by NIH/NIDA, we are developing QUITAdvisorMD: a point-of-care, patient-centered resource for counseling patients who smoke or use tobacco products. It is based on the principles of Motivational Interviewing, a non-confrontational and very effective method for intervening and treating these patients; the 5 A's of behavioral interventions; and the Transtheoretical Model of Change. Through a point and click interface, the tool uses a series of interview questions designed to motivate patients to stop smoking by first assessing their stage of change and then offering effective stage-based interventions and interview techniques. The tool also offers stage-tailored patient information, a clinician educational reference, and the ability to communicate support information patients via email and/or text message.

Intervention(s) in this Clinical Trial

• Other: QuitAdvisorMD Software Algorithm
  • QuitAdvisorMD, a set of brief clinical assessments, counseling scripts and intervention instruments for smoking cessation in primary care settings
• Behavioral: Standard Smoking Cessation Counseling
  • Standard Smoking Cessation Counseling

Arms, Groups and Cohorts in this Clinical Trial

• Experimental: Software Assisted Lifestyle Counseling
• Active Comparator: Lifestyle Counseling
  • Status quo smoking cessation counseling.

Primary Measures

• The goal of the evaluation is to assess the ability of QuitAdvisorMD to influence smoking cessation as measured by the primary outcome of the increase in physician initiated smoking cessation counseling.
  • Time Frame: 12 Months
    Safety Issue?: No

Secondary Measures

• Secondary outcomes will include, 1) the increase in ability of clinicians to provide appropriate stage-based smoking cessation assistance, and 2) the increase in patient quit attempts.
  • Time Frame: 12 Months
    Safety Issue?: No

Inclusion Criteria:

• any physician providing care for members of Southern Health through primary care and have access to a point-of-care computing device (Smartphone, desktop PC, etc) during patient visits.

Exclusion Criteria:

• Lack of appropriate computing device

Gender Eligibility for this Clinical Trial: Both

Minimum Age for this Clinical Trial: N/A

Maximum Age for this Clinical Trial: N/A

Are Healthy Volunteers Accepted for this Clinical Trial?: Accepts Healthy Volunteers

Lead Investigator: National Institute on Drug Abuse (NIDA) NIH

Overall Clinical Trial Officials and Contacts

Gerge Reynolds, BA Principal Investigator Silverchair, Inc  

Overall Contact: Sandra Pelletier, PhD 434-924-5509 SLP6U@hscmail.mcc.virginia.edu

Information obtained from ClinicalTrials.gov on February 12, 2012

Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT01065493

Study ID Number: R44 DA026682

ClinicalTrials.gov Identifier: NCT01065493

Health Authority: United States: Federal Government